Genomic characterization of clinically significant blood group variants in Aboriginal Australians

Blood Transfus. 2024 Nov;22(6):464-474. doi: 10.2450/BloodTransfus.664. Epub 2024 Mar 11.

Abstract

Background: Hematological disorders are often treated with blood transfusions. Many blood group antigens and variants are population-specific, and for patients with rare blood types, extensive donor screening is required to find suitable matches for transfusion. There is a scarcity of knowledge regarding blood group variants in Aboriginal Australian populations, despite a higher need for transfusion due to the higher prevalence of renal diseases and anemia.

Materials and methods: In this study, we applied next-generation sequencing and analysis to 245 samples obtained from Aboriginal Australians from South-East Queensland, to predict antigen phenotypes for 36 blood group systems.

Results: We report potential weak antigens in blood group systems RH, FY and JR that have potential clinical implications in transfusion and pregnancy settings. These include partial DIII type 4, weak D type 33, and Del RHD (IVS2-2delA). The rare Rh phenotypes D+ C+ E+ c- e+ and D+ C+ E+ c+ e- were also detected.

Discussion: The comprehensive analyses of blood group genetic variant profiles identified in this study will provide insight and an opportunity to improve Aboriginal health by aiding in the identification of appropriate blood products for population-specific transfusion needs.

MeSH terms

  • Australia / epidemiology
  • Australian Aboriginal and Torres Strait Islander Peoples*
  • Blood Group Antigens* / genetics
  • Female
  • Genetic Variation
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Male
  • Pregnancy
  • Rh-Hr Blood-Group System / genetics

Substances

  • Blood Group Antigens
  • Rh-Hr Blood-Group System